INTRODUCTION: In support of global targets to end HIV/AIDS and tuberculosis (TB) by 2030, we reviewed interventions aiming to improve TB case-detection and anti-TB treatment among people living with HIV (PLHIV) and HIV testing and antiretroviral treatment initiation among people with TB disease in low- and middle-income countries (LMICs). METHODS: We conducted a systematic review of comparative (quasi-)experimental interventional studies published in Medline or EMBASE between January 2003-July 2021. We performed random-effects effect meta-analyses (DerSimonian and Laird method) for interventions that were homogenous (based on intervention descriptions); for others we narratively synthesized the intervention effect. Studies were assessed usi...
BackgroundTo inform policy and implementation that can enhance prevention and improve tuberculosis (...
BACKGROUND: People who inject drugs (PWID) are at increased risk of tuberculosis (TB) and reduced re...
Introduction: Tuberculosis (TB) remains the most common cause of death among people living with HIV....
IntroductionIn support of global targets to end HIV/AIDS and tuberculosis (TB) by 2030, we reviewed ...
OBJECTIVES: Given the imperative to scale up integrated tuberculosis (TB) and HIV services in settin...
Background Programs that integrate tuberculosis (TB) and human immunodeficiency virus (HIV) treatme...
PURPOSE OF REVIEW: Globally, the number of deaths associated with tuberculosis (TB) and HIV coinfect...
INTRODUCTION: Programmes that merge management of Human Immunodeficiency Virus (HIV) and tuberculosi...
A large and compelling clinical evidence base has shown that integrated TB and HIV services leads to...
Background A large and compelling clinical evidence base has shown that integrated TB and HIV servi...
Introduction Programmes that merge management of Human Immunodeficiency Virus (HIV) and tuberculosi...
CITATION: Charles, M. K., et al. 2016. Implementation of tuberculosis intensive case finding, isonia...
Tuberculosis (TB) is the leading cause of death among PLHIV and multidrug-resistant-TB (MDR-TB) is a...
Kielmann, Karina - ORCID 0000-0001-5519-1658 https://orcid.org/0000-0001-5519-1658Objectives: To ev...
BackgroundTo inform policy and implementation that can enhance prevention and improve tuberculosis (...
BackgroundTo inform policy and implementation that can enhance prevention and improve tuberculosis (...
BACKGROUND: People who inject drugs (PWID) are at increased risk of tuberculosis (TB) and reduced re...
Introduction: Tuberculosis (TB) remains the most common cause of death among people living with HIV....
IntroductionIn support of global targets to end HIV/AIDS and tuberculosis (TB) by 2030, we reviewed ...
OBJECTIVES: Given the imperative to scale up integrated tuberculosis (TB) and HIV services in settin...
Background Programs that integrate tuberculosis (TB) and human immunodeficiency virus (HIV) treatme...
PURPOSE OF REVIEW: Globally, the number of deaths associated with tuberculosis (TB) and HIV coinfect...
INTRODUCTION: Programmes that merge management of Human Immunodeficiency Virus (HIV) and tuberculosi...
A large and compelling clinical evidence base has shown that integrated TB and HIV services leads to...
Background A large and compelling clinical evidence base has shown that integrated TB and HIV servi...
Introduction Programmes that merge management of Human Immunodeficiency Virus (HIV) and tuberculosi...
CITATION: Charles, M. K., et al. 2016. Implementation of tuberculosis intensive case finding, isonia...
Tuberculosis (TB) is the leading cause of death among PLHIV and multidrug-resistant-TB (MDR-TB) is a...
Kielmann, Karina - ORCID 0000-0001-5519-1658 https://orcid.org/0000-0001-5519-1658Objectives: To ev...
BackgroundTo inform policy and implementation that can enhance prevention and improve tuberculosis (...
BackgroundTo inform policy and implementation that can enhance prevention and improve tuberculosis (...
BACKGROUND: People who inject drugs (PWID) are at increased risk of tuberculosis (TB) and reduced re...
Introduction: Tuberculosis (TB) remains the most common cause of death among people living with HIV....